[Clinical advances in bispecific antibodies for hematological malignancies]. [PDF]
Zhonghua Xue Ye Xue Za Zhi, 2023 Cai YM, Wu DP, Xu Y.
europepmc +1 more source
[Clinical Progress and Prospects of Antibody-drug Conjugates in Advanced NSCLC]. [PDF]
Zhongguo Fei Ai Za ZhiZhong Y, Wang J, Wu L.
europepmc +1 more source
[Correlation of anti-phosphatidylserine/prothrombin antibodies with unexplained recurrent miscarriages]. [PDF]
Beijing Da Xue Xue Bao Yi Xue Ban, 2023 Yao ZQ +7 more
europepmc +1 more source
α1受体拮抗剂对糖尿病鼠肾组织Ⅳ型胶原及Smad2/3表达的影响
Linchuang shenzangbing zazhi, 2013 目的 探讨α1受体拮抗剂多沙唑嗪对糖尿病大鼠的肾脏保护作用。方法 动物分为正常对照组、单纯糖尿病组、糖尿病鼠抗α1受体抗体介导组、糖尿病鼠抗α1受体抗体介导并多沙唑嗪于预组和糖尿病鼠无抗α1受体抗体介导多沙唑嗪干预组,腹腔注射链脲佐菌素法建立糖尿病大鼠模型,尾静脉注射抗α1受体抗体的方法进行介导,干预组给予多沙唑嗪3.6 mg·kg-1·d-1。观察肾脏超微病理改变。免疫组化法检测肾组织Ⅳ型胶原和Smad2/3。结果 糖尿病鼠抗α1受体抗体介导组Ⅳ型胶原和Smad2/3蛋白的表达较单纯糖尿病组明显增多 ...
doaj
[Anti-HMGCR immune-mediated necrotizing myopathy: A case report]. [PDF]
Beijing Da Xue Xue Bao Yi Xue Ban, 2023 Zhang YJ +6 more
europepmc +1 more source
Immunity/inflammation-mediated pathophysiological mechanisms of atherosclerosis and clinical applications of antibody technology [PDF]
, 2013 Matsuura, Eiji
core +1 more source
[Rheumatic disease spectrum and immunological profile of anti-PM/Scl antibodies in idiopathic inflammatory myopathies]. [PDF]
Beijing Da Xue Xue Bao Yi Xue BanLian Y +5 more
europepmc +1 more source
[Recent advances in antibody-drug conjugates for metastatic castration-resistant prostate cancer]. [PDF]
Zhejiang Da Xue Xue Bao Yi Xue BanXu J, Ma Y, Hu P, Yao J, Chen H, Ma Q.
europepmc +1 more source
[Expression of thyroglobulin antibody and thyroid peroxidase antibody in children with immune thrombocytopenia]. [PDF]
Zhongguo Dang Dai Er Ke Za Zhi, 2022 Wang XM +4 more
europepmc +1 more source